Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023
Authors' conclusion
About half of US adults with doctor-diagnosed arthritis report activity limitations due to arthritis, and the Healthy People 2030 objective for an AAAL prevalence of 46.8% has not been met.
Study context
- Population
- US adults who reported having doctor-diagnosed arthritis
- Exposure
- Arthritis-attributable activity limitations (AAAL) prevalence 2023 vs 2019
- Outcome
- Prevalence of arthritis-attributable activity limitations (AAAL)
- Follow-up
- 2023
Methodological detailsNational Health Interview Survey 2019 and 2023, age-standardized
- National Health Interview Survey 2019 and 2023
- Age-standardized
Main finding
As reported in the abstract
Age-adjusted AAAL prevalence
2023
47.8%
24.8 million events
Observational data: associations, not effects.
Further findings
| Outcome | 2023 | 2019 |
|---|---|---|
| Change in age-adjusted AAAL prevalence, 2019 to 2023 | 47.8% (95% CI 45.0%–50.7%) | 49.2% (95% CI 46.7%–51.6%) |
Change in age-adjusted AAAL prevalence, 2019 to 2023
- Decline from 2019 to 2023 not statistically significant
Original publication
Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023. Arthritis Care Res (Hoboken). Published 29 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →